Fact.MR’s medical membranes industry analysis shows that the global market was valued at US$ 2 Bn in 2020, and is projected to top a valuation of US$ 3 Bn by 2031, expanding at a CAGR of 7%. Sales of for ultrafiltration membranes are projected to reach a valuation of US$ 1 Bn by 2031, surging at a CAGR of 7% over the next ten years, with that for microfiltration membranes increasing at 6%.
Detailed Insights Offered in Medical Membranes Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis
- COVID-19 Impact on Demand for Medical Membranes and How to Navigate
- Recommendation on Key Winning Strategies
Sales Analysis of Medical Membranes from 2016 to 2020 Vs Demand Outlook for 2021 to 2031
As per Fact.MR - a market research and competitive intelligence provider, the global market for medical membranes was valued at US$ 1.3 Bn in 2016 and is anticipated to expand at a CAGR of 7% to top US$ 3 Bn by 2031.
Medical membrane technology is of major importance in medical applications, in particular in a number of lifesaving treatment methods. Its major medical applications include drug delivery, tissue regeneration, artificial organs, and diagnostic devices such as medical device coatings and bio-separations.
Some of the other applications of membrane technologies, such as separation, and purification are highly in demand in the pharmaceutical industry. Medical membranes have high precision for separation and assist in the processing of products of high purity.
In addition, they provide comparatively greater selectivity toward the critical components and thus help to improve wastewater treatment.
Owing to increase in their application across various end-use industries such as biotechnology, pharmaceutical, and healthcare, the global market for medical membrane has witnessed unprecedented growth in recent years.
What are the Key Opportunities Awaiting Manufacturers of Medical Membranes?
Rise in prevalence of diseases globally, developments in biotechnology, life science, and healthcare industries, surge in demand for high-purity products, and increase in medical membrane consumption in the medical industry are some of the key driving forces of the global industry for medical membranes.
In addition, in the last few years, there have been growing cases of end-stage renal disease and diabetes due to upsurge in geriatric population and increase in the number of obese people worldwide.
The pharmaceutical, healthcare, and biotechnology industries are experiencing tremendous growth in developing countries as the ageing population rises. Furthermore, development of the healthcare industry in emerging economies is expected to provide lucrative opportunities for business growth during the forecast period.
Avail customized purchase options for your needs
What are the Restraints being Faced by Suppliers of Medical Membranes?
Medical membranes, though made of medical grade polymers, have to undergo in-process validation for certification. This process takes 3-6 months. After the membrane or membrane component has been validated and certified, the device that uses the membrane also needs to be certified.
Despite high demand for medical products and devices, manufacturers are facing several regulatory barriers due to multi-layered regulations set by the FDA.
The lifespan of a particular type of membrane used in a separation process for medical application is constrained and, therefore, needs replacement after a certain period of time.
Medical membranes used in various procedures are prone to fouling, after which, they do not have the same operational excellence.
During the treatment of pharmaceutical water or during any filtration/purification process, some unwanted components such as iron, manganese, calcium, sulfate, and other ions form precipitate on the membrane surface. Damaging the properties of the membrane.
Hence, the long validation process along with high maintenance costs of medical membranes are acting as restraining factors for the growth of market.
Which Region Offers Lucrative Opportunity for Medical Membrane Providers?
Europe accounts for around 35% of the global market share for medical membranes.
Europe a leader in pharmaceutical manufacturing and dialyzer demand. Growth is fuelled by the increasing ESRD (end-stage renal failure) patient pool, rising availability of better diagnosis facilities, and high incidence and prevalence of chronic diseases such as diabetes and hypertension.
An Adaptive Approach to Modern-day Research Needs
How is Demand for Medical Membranes Shaping Up across Developing and Developed Economies?
- The medical membranes market in the U.S. is estimated to reach a valuation of US$ 735 Mn in the year 2021.
- China, the world’s second largest economy, is forecast to reach an estimated market size of US$ 350 Mn in the year 2031, trailing a CAGR of 9% through the analysis period.
- Among the other noteworthy geographic markets are Japan and Canada, each forecast to expand at CAGRs of 4% and 6%, respectively, over the next ten years.
- Within Europe, the market in Germany is forecast to expand at approximately 7% CAGR, while the Rest of European market will reach US$ 386 Mn by the end of 2031.
These markets are benefiting from the rise in need for high purity products for meeting the needs of biotechnological advancements, increase in disease prevalence, and growth of the healthcare and life science industry.
Other emerging applications include the venting and gas filtration, sample preparation and infusion therapy, pre-filtration, and sterile filtration among others. In addition, medical membranes are finding extensive application across the haemodialysis and pharmaceutical filtration process.
Growth in number of patients who are suffering from end-stage renal disease (ESRD) needing dialysis is pushing up demand for membranes for blood purification and filtration. As a result, there is an increased demand for products with high purity due to the expansion of healthcare and pharmaceutical industries, while contributing growth of the medical membranes market globally.
Why Has Demand for Polysulfone and Polyether Sulfone Membranes Increased Over the Past Years?
Polysulfone (PSU) & polyether sulfone (PESU) membranes have emerged as the largest segment in the global market for medical membranes.
Widespread use of this form of material to remove particulates during general filtration and its low protein and drug binding characteristics make it ideal for various end-user sectors such as the biotechnology, pharmaceutical, life sciences, and healthcare industries.
This is the main reason for why polysulfone and polyether sulfone membranes are contributing to revenue generated in the global market.
Which Technology Dominates the Industry for Medical Membranes?
Demand for nanofiltration medical membranes is expected to reach a valuation of US$ 730 Mn by 2031.
Nanofiltration technology dominates the global market for medical membranes. This is attributed to the fact that, with increase in flow rates, nanofiltration is achieved at reduced operating pressures.
Applicability of nanofiltration in areas such as pharmaceuticals and fine chemicals has been extended by research & development of solvent-stable membranes, thus driving the growth of nanofiltration technology.
Which Application of Medical Membranes is the Highest in Terms of Revenue?
Pharmaceutical filtration has garnered the largest share of around 30%, in terms of revenue.
High rate of occurrence of renal diseases, advances in medical technology, development of pharmaceutical & healthcare industries, and rise in demand for high-purity materials & medicines are driving the growth of the pharmaceutical filtration segment in the global market.
Interested to Procure The Data
Key players are adopting several organic and inorganic growth strategies to strengthen their foothold in the market. Many companies expanded their production facilities and acquired other businesses to strengthen their position in the global market.
Some of the key developments are:
- In 2017, 3M Company (US) made an investment of US$ 40 Mn to expand its dialysis membrane production facility. This expansion will help company to increase its customer base and strengthen its foothold in the market.
- In August 2017, Merck Millipore (US) acquired Natrix Separation (Canada), which is hydrogel membrane provider. This acquisition will help Merck Millipore (US) in increasing its product portfolio, customer base, and strengthen its foothold in North America.
- In December 2017, Asahi Kasei Medical announced the construction of a new plant for the spinning of cellulose hollow fiber membranes for its virus removal filters called Planova.
In September 2016, Sartorius launched a PES membrane, which is integrated into the sterile Sartocon benchtop and production scale filtration assemblies.
Medical Membranes Market Report Scope
Historical Data Available for
US$ Mn for Value & ‘000 Units for Volume
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Key Market Segments Covered in Medical Membranes Industry Research
- Polysulfone PSU & Polyethersulfone PESU
- Hydrophilic polyvinylidene fluoride PVDF
- Polytetrafluoroethylene PTFE
- Polypropylene PP
- Modified Acrylics
By Process Technology
- Reverse Osmosis
- Gas Filtration
- Medical Membranes Used in Pharmaceutical Filtration
- Medical Membranes Used in Haemodialysis
- Medical Membranes Used in Drug Delivery
- Medical Membranes Used in IV Infusion & Sterile Filtration
- Medical Membranes Used in Bio-artificial Processes
- FAQs -
The global medical membranes market topped US$ 2 Bn in 2020, and is projected to reach a valuation of over US$ 3 Bn by 2031.
Increasing use of medical membranes owing to growing need for high-purity selective separation in various end-use applications is a major factor driving demand.
Hangzhou Cobetter Filtration Equipment, Koch Membrane Systems, Merck Group, Mann+Hummel, Sartorius AG, W. L. Gore & Associates, and 3M Company are major companies providing medical membranes.
Europe accounts for 35% of the global revenue share for medical membranes.
Pharmaceutical filtration application is projected to catalyze demand for medical membranes over the coming ten years.
Increase in incidence of diabetes and kidney disease worldwide is fuelling demand for medical membranes in haemodialysis applications.
Demand for medical membranes in the U.S. is estimated to top US$ 735 Mn in 2021.
Demand for nanofiltration membranes is expected to top US$ 730 Mn by 2031-end.
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.